Thrombosis in vasculitis: from pathogenesis to treatment

[1]  O. Ozcebe,et al.  Behçet's disease. , 2019, The New England journal of medicine.

[2]  Rohit Sharma.  Revised International Chapel Hill Consensus Conference nomenclature of vasculitides , 2016, Radiopaedia.org.

[3]  A. Amedei,et al.  Microparticles: Bridging the Gap between Autoimmunity and Thrombosis , 2015, Seminars in Thrombosis & Hemostasis.

[4]  E. Matteson,et al.  Cardiovascular Risk and Acute Coronary Syndrome in Giant Cell Arteritis: A Population‐Based Retrospective Cohort Study , 2015, Arthritis care & research.

[5]  B. Baslund,et al.  High Risk of Pulmonary Embolism and Deep Venous Thrombosis but Not of Stroke in Granulomatosis With Polyangiitis (Wegener's) , 2014, Arthritis care & research.

[6]  Hyon K. Choi,et al.  The risk of deep venous thrombosis and pulmonary embolism in giant cell arteritis: a general population-based study , 2014, Annals of the rheumatic diseases.

[7]  C. Kallenberg.  Key advances in the clinical approach to ANCA-associated vasculitis , 2014, Nature Reviews Rheumatology.

[8]  M. López-Hoyos,et al.  Effect of antiplatelet/anticoagulant therapy on severe ischemic complications in patients with giant cell arteritis: a cumulative meta-analysis. , 2014, Autoimmunity reviews.

[9]  L. Pontes-de-carvalho,et al.  Neutrophil-derived microparticles induce myeloperoxidase-mediated damage of vascular endothelial cells , 2014, BMC Cell Biology.

[10]  F. Shahram,et al.  The relationship between plasma homocysteine level and HLA‐B51 in patients with Behcet's disease: a case‐control study , 2014, International journal of rheumatic diseases.

[11]  F. Sung,et al.  Increased Risks of Deep Vein Thrombosis and Pulmonary Embolism in Sjögren Syndrome: A Nationwide Cohort Study , 2014, The Journal of Rheumatology.

[12]  Y. Béjot,et al.  Stroke associated with giant cell arteritis: a population-based study , 2014, Journal of Neurology, Neurosurgery & Psychiatry.

[13]  I. Olivieri,et al.  The International Criteria for Behçet's Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria , 2014 .

[14]  J. Antón,et al.  Diagnosis and classification of Kawasaki disease. , 2014, Journal of Autoimmunity.

[15]  M. D’Elios,et al.  Behçet’s syndrome pathophysiology and potential therapeutic targets , 2014, Internal and Emergency Medicine.

[16]  R. van Oerle,et al.  Patients with Antineutrophil Cytoplasmic Antibodies Associated Vasculitis in Remission Are Hypercoagulable , 2013, The Journal of Rheumatology.

[17]  C. A. Caldas,et al.  Antiphospholipid syndrome and polyarteritis nodosa: a diagnostic and therapeutic challenge , 2013, Rheumatology International.

[18]  Jingwen Zhang,et al.  Thrombosis Warning in Children Suffering from Henoch-Schonlein Purpura , 2013, Indian journal of dermatology.

[19]  F. Sung,et al.  Rheumatoid arthritis increases the risk of deep vein thrombosis and pulmonary thromboembolism: a nationwide cohort study , 2013, Annals of the rheumatic diseases.

[20]  A. Giatromanolaki,et al.  Tissue factor expression in neutrophil extracellular traps and neutrophil derived microparticles in antineutrophil cytoplasmic antibody associated vasculitis may promote thromboinflammation and the thrombophilic state associated with the disease , 2013, Annals of the rheumatic diseases.

[21]  P. Hissaria,et al.  Clinical and laboratory characteristics of 19 patients with Churg–Strauss syndrome from a single South Australian centre , 2013, Internal medicine journal.

[22]  E. Matteson,et al.  Statin Use in Giant Cell Arteritis: A Retrospective Study , 2013, The Journal of Rheumatology.

[23]  B. Al‐Ani.  Simvastatin inhibits neutrophil degranulation induced by anti-neutrophil cytoplasm auto-antibodies and N-formyl-methionine-leucine-phenylalanine (fMLP) peptide. , 2013, Saudi medical journal.

[24]  D. Valla,et al.  Behcet’s disease in budd-chiari syndrome , 2013, Orphanet Journal of Rare Diseases.

[25]  A. Gaffo.  Thrombosis in vasculitis. , 2013, Best practice & research. Clinical rheumatology.

[26]  R. Falk,et al.  Pathogenesis of antineutrophil cytoplasmic autoantibody-associated small-vessel vasculitis. , 2013, Annual review of pathology.

[27]  Ceyran,et al.  Die chirurgische Behandlung des M. Behçet , 2013 .

[28]  B. Engelmann,et al.  Thrombosis as an intravascular effector of innate immunity , 2012, Nature Reviews Immunology.

[29]  M. Colombo,et al.  NEUTROPHIL EXTRACELLULAR TRAPS MEDIATE TRANSFER OF CYTOPLASMIC NEUTROPHIL ANTIGENS TO MYELOID DENDRITIC CELLS TOWARDS ANCA INDUCTION AND ASSOCIATED AUTOIMMUNITY RUNNING TITLE : NET / mDC cross-talk triggers autoimmunity , 2012 .

[30]  P. Lesavre,et al.  Endothelium-neutrophil interactions in ANCA-associated diseases. , 2012, Journal of the American Society of Nephrology : JASN.

[31]  A. Marzano,et al.  Hypereosinophilic syndrome, Churg-Strauss syndrome and parasitic diseases: possible links between eosinophilia and thrombosis. , 2012, Current vascular pharmacology.

[32]  H. van Loveren,et al.  Statin-Associated Polymyalgia Rheumatica. An Analysis Using WHO Global Individual Case Safety Database: A Case/Non-Case Approach , 2012, PloS one.

[33]  C. Chung,et al.  Ischemic Stroke in Takayasu's Arteritis: Lesion Patterns and Possible Mechanisms , 2012, Journal of clinical neurology.

[34]  O. Köse.  Development of Immunopathogenesis Strategies to Treat Behçet's Disease , 2012, Pathology research international.

[35]  I. Baumgartner,et al.  Behçet's disease: Successful treatment with infliximab in 7 patients with severe vascular manifestations. A retrospective analysis , 2012, Arthritis care & research.

[36]  K. Aksu,et al.  Inflammation-induced thrombosis: mechanisms, disease associations and management. , 2012, Current pharmaceutical design.

[37]  A. Mantovani,et al.  Selective up-regulation of the soluble pattern-recognition receptor pentraxin 3 and of vascular endothelial growth factor in giant cell arteritis: relevance for recent optic nerve ischemia. , 2012, Arthritis and rheumatism.

[38]  J. Sundquist,et al.  Risk of pulmonary embolism in patients with autoimmune disorders: a nationwide follow-up study from Sweden , 2012, The Lancet.

[39]  E. Alpsoy.  New Evidence-Based Treatment Approach in Behçet's Disease , 2011, Pathology research international.

[40]  C. Doglioni,et al.  Pentraxin-3 as a Marker of Disease Activity in Takayasu Arteritis , 2011, Annals of Internal Medicine.

[41]  M. Macey,et al.  Age, gender and disease-related platelet and neutrophil activation ex vivo in whole blood samples from patients with Behçet's disease. , 2011, Rheumatology.

[42]  D. Klatzmann,et al.  Critical role of IL-21 in modulating TH17 and regulatory T cells in Behçet disease. , 2011, The Journal of allergy and clinical immunology.

[43]  E. Onur,et al.  Oxidative stress impairs endothelial nitric oxide levels in Behçets’ disease , 2011, Cutaneous and ocular toxicology.

[44]  P. Sfikakis,et al.  Anti-TNF agents for Behçet's disease: analysis of published data on 369 patients. , 2011, Seminars in arthritis and rheumatism.

[45]  S. Yurdakul,et al.  Behçet’s Syndrome and Thrombosis , 2011, Mediterranean journal of hematology and infectious diseases.

[46]  P. Merkel,et al.  A model to predict cardiovascular events in patients with newly diagnosed Wegener's granulomatosis and microscopic polyangiitis , 2011, Arthritis care & research.

[47]  G. Vaiopoulos,et al.  Evaluation of current therapeutic strategies in Behçet’s disease , 2011, Clinical Rheumatology.

[48]  M. Schirmer,et al.  Major vessel involvement in Behçet's disease: an update , 2011, Current opinion in rheumatology.

[49]  R. Bertina,et al.  Anti-plasminogen antibodies compromise fibrinolysis and associate with renal histology in ANCA-associated vasculitis. , 2010, Journal of the American Society of Nephrology : JASN.

[50]  M. Margaglione,et al.  Eosinophilia and Thrombophilia in Churg Strauss Syndrome: A Clinical and Pathogenetic Overview , 2010, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

[51]  F. Dentali,et al.  Homocysteine in Vascular Behçet Disease: A Meta-Analysis , 2010, Arteriosclerosis, thrombosis, and vascular biology.

[52]  A. Dogan,et al.  Effects of Atorvastatin and Lisinopril on Endothelial Dysfunction in Patients with Behçet's Disease , 2010, Echocardiography.

[53]  E. Rosenstein,et al.  ANCA‐positive vasculitis associated with simvastatin/ezetimibe: expanding the spectrum of statin‐induced autoimmunity? , 2010, International journal of rheumatic diseases.

[54]  G. Poli,et al.  A study on thrombophilic factors in Italian Behcet's patients. , 2010, Joint, bone, spine : revue du rhumatisme.

[55]  H. Mariz,et al.  Antiplatelet therapy for the prevention of arterial ischemic events in takayasu arteritis. , 2010, Circulation journal : official journal of the Japanese Circulation Society.

[56]  M. La Regina,et al.  Behçet’s Disease as a Model of Venous Thrombosis , 2010, The open cardiovascular medicine journal.

[57]  C. Ferro,et al.  Increased incidence of cardiovascular events in patients with antineutrophil cytoplasmic antibody-associated vasculitides: a matched-pair cohort study. , 2009, Arthritis and rheumatism.

[58]  M. Adams,et al.  Thrombosis in systemic lupus erythematosus. , 2009, Seminars in thrombosis and hemostasis.

[59]  O. Steichen.  Comment on: Risk factors for severe cranial ischaemic events in an Italian population-based cohort of patients with giant cell arteritis. , 2009, Rheumatology.

[60]  M. González-Gay,et al.  Strokes at Time of Disease Diagnosis in a Series of 287 Patients With Biopsy-Proven Giant Cell Arteritis , 2009, Medicine.

[61]  N. Maugeri,et al.  Translational Mini‐Review Series on Immunology of Vascular Disease: Mechanisms of vascular inflammation and remodelling in systemic vasculitis , 2009, Clinical and experimental immunology.

[62]  L. Dreyer,et al.  Increased morbidity from ischemic heart disease in patients with Wegener's granulomatosis. , 2009, Arthritis and rheumatism.

[63]  A. Wolberg,et al.  Antibodies with dual reactivity to plasminogen and complementary PR3 in PR3-ANCA vasculitis. , 2008, Journal of the American Society of Nephrology : JASN.

[64]  R. Seror,et al.  High frequency of venous thromboembolic events in Churg–Strauss syndrome, Wegener’s granulomatosis and microscopic polyangiitis but not polyarteritis nodosa: a systematic retrospective study on 1130 patients , 2008, Annals of the rheumatic diseases.

[65]  M. Haroon,et al.  A case of ANCA-associated systemic vasculitis induced by atorvastatin , 2008, Clinical Rheumatology.

[66]  A. Silman,et al.  EULAR recommendations for the management of Behçet disease , 2008, Annals of the rheumatic diseases.

[67]  C. Kallenberg,et al.  Venous thromboembolism in ANCA-associated vasculitis--incidence and risk factors. , 2007, Rheumatology.

[68]  P. Merkel,et al.  The frequency of anticardiolipin antibodies and genetic mutations associated with hypercoagulability among patients with Wegener's granulomatosis with and without history of a thrombotic event. , 2007, The Journal of rheumatology.

[69]  D. Formisano,et al.  PlA1/A2 polymorphism of the platelet glycoprotein receptor IIIA and risk of cranial ischemic complications in giant cell arteritis. , 2007, Arthritis and rheumatism.

[70]  B. Engelmann,et al.  bloodjournal.hematologylibrary.org at PENN STATE UNIVERSITY on February 23, 2013. For personal use only. , 2006 .

[71]  M. Nazıroğlu,et al.  Asymmetric dimethylarginine and nitric oxide levels as signs of endothelial dysfunction in Behcet's disease. , 2006, Annals of clinical and laboratory science.

[72]  R. Dişçi,et al.  Vascular involvement in Behçet's disease: a retrospective analysis of 2319 cases , 2006, International journal of dermatology.

[73]  J. C. Cohen Tervaert,et al.  Antiendothelial cell antibodies in vasculitis and connective tissue disease , 2006, Annals of the rheumatic diseases.

[74]  D. Corella,et al.  Thrombophilic risk factors and homocysteine levels in Behçet’s disease in eastern Spain and their association with thrombotic events , 2006, Thrombosis and Haemostasis.

[75]  S. Androudi.  Current concepts in the etiology and treatment of Behçet disease. , 2006, Survey of ophthalmology.

[76]  H. Rupprecht,et al.  Thromboembolic events as a complication of antineutrophil cytoplasmic antibody-associated vasculitis. , 2006, Arthritis and rheumatism.

[77]  Ö. Demir,et al.  Characteristics of vascular involvement in Behçet's disease , 2006, Scandinavian journal of rheumatology.

[78]  S. Gröschel,et al.  Vascular Dendritic Cells in Giant Cell Arteritis , 2005, Annals of the New York Academy of Sciences.

[79]  A. Doria,et al.  Behçet’s disease and cardiovascular involvement , 2005, Lupus.

[80]  Y. Turkoz,et al.  Serum Levels of Soluble P-Selectin Are Increased and Associated With Disease Activity in Patients With Behçet's Syndrome , 2005, Mediators of inflammation.

[81]  A. Kızıltunç,et al.  Levels of soluble E-selectin in patients with active Behçet’s disease , 2005, Clinical Rheumatology.

[82]  M. González-Gay,et al.  Influence of Traditional Risk Factors of Atherosclerosis in the Development of Severe Ischemic Complications in Giant Cell Arteritis , 2004, Medicine.

[83]  M. Ehrenfeld,et al.  Thrombophilic factors are not the leading cause of thrombosis in Behçet’s disease , 2004, Annals of the rheumatic diseases.

[84]  I. Olivieri,et al.  Factor V Leiden and prothrombin gene G20210A mutations in Italian patients with Behçet's disease and deep vein thrombosis. , 2004, Arthritis and rheumatism.

[85]  M. López-Hoyos,et al.  Homocysteine levels in polymyalgia rheumatica and giant cell arteritis: influence of corticosteroid therapy. , 2003, Rheumatology.

[86]  H. Ceyran,et al.  Surgical treatment of vasculo-Behçet's disease. A review of patients with concomitant multiple aneurysms and venous lesions. , 2003, VASA. Zeitschrift fur Gefasskrankheiten.

[87]  Dolors Colomer,et al.  Elevated Production of Interleukin-6 Is Associated With a Lower Incidence of Disease-Related Ischemic Events in Patients With Giant-Cell Arteritis: Angiogenic Activity of Interleukin-6 as a Potential Protective Mechanism , 2003, Circulation.

[88]  N. Akar,et al.  Factor V Gene (1691A and 4070G) and Prothrombin Gene 20210A Mutations in Patients with Behçet’s Disease , 2003, Pathophysiology of Haemostasis and Thrombosis.

[89]  N. Seyahi,et al.  The Long-Term Mortality and Morbidity of Behçet Syndrome: A 2-Decade Outcome Survey of 387 Patients Followed at a Dedicated Center , 2003, Medicine.

[90]  P. Meroni,et al.  Plasma levels of soluble endothelial cell protein C receptor in patients with Wegener’s granulomatosis , 2002, Clinical and experimental immunology.

[91]  J. Kooner,et al.  Vascular endothelial function and oxidative stress mechanisms in patients with Behçet's syndrome. , 2001, Journal of the American College of Cardiology.

[92]  Z. Tazi-Mezalek,et al.  Manifestations cardiaques et pulmonaires artrielles au cours dune maladie de Behet , 2000 .

[93]  M. Cutolo,et al.  Risk factors for thrombotic events in giant cell arteritis and polymyalgia rheumatica. , 1998, British journal of rheumatology.

[94]  N. Allı,et al.  Protein C and protein S activities in Behçet's disease as risk factors of thrombosis. , 1998, International journal of dermatology.

[95]  R. Manna,et al.  Anticardiolipin antibodies in giant cell arteritis and polymyalgia rheumatica: a study of 40 cases. , 1998, British journal of rheumatology.

[96]  C. Santosh,et al.  Cerebral venous thrombosis in Behçet’s disease , 1997, Journal of neurology, neurosurgery, and psychiatry.

[97]  J. Tervaert,et al.  Specificity, pathogenecity, and clinical value of antiendothelial cell antibodies. , 1997, Seminars in arthritis and rheumatism.

[98]  M. Inanç,et al.  Coagulation factor V gene mutation increases the risk of venous thrombosis in behçet's disease. , 1996, British journal of rheumatology.

[99]  Ş. Kirazlı,et al.  Circulating Thrombomodulin as a Clue of Endothelial Damage in Behçet’s Disease , 1996, Thrombosis and Haemostasis.

[100]  E. Silvestri,et al.  Cardiovascular Issues: Aneurysms and Pseudoaneurysms, Thrombosis, Atherosclerosis, and Cardiac Involvement , 2014 .

[101]  Queiroz,et al.  The International Criteria for Behçet's Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria , 2014, Journal of the European Academy of Dermatology and Venereology : JEADV.

[102]  M. Gonzalez-gay,et al.  Biopsy-proven giant cell arteritis patients with coronary artery disease have increased risk of aortic aneurysmal disease and arterial thrombosis. , 2013, Clinical and experimental rheumatology.

[103]  P. Merkel,et al.  2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. , 2013, Arthritis and rheumatism.

[104]  N. Klein,et al.  Anti-neutrophil cytoplasmic antibodies stimulate release of neutrophil microparticles. , 2012, Journal of the American Society of Nephrology : JASN.

[105]  D. Formisano,et al.  Risk factors for severe cranial ischaemic events in an Italian population-based cohort of patients with giant cell arteritis. , 2009, Rheumatology.

[106]  B. Thiers.  Etanercept plus standard therapy for Wegener's granulomatosis. , 2005, The New England journal of medicine.

[107]  J. Stone.  Etanercept plus Standard Therapy for Wegener's Granulomatosis , 2005 .

[108]  G. Espinosa,et al.  Vascular involvement in Behçet's disease: relation with thrombophilic factors, coagulation activation, and thrombomodulin. , 2002, The American journal of medicine.

[109]  Z. Tazi-Mezalek,et al.  [Cardiac and pulmonary artery manifestations during Behcet's disease]. , 2000, La Revue de medecine interne.

[110]  A. Gürler,et al.  Plasma von Willebrand factor, tissue plasminogen activator, plasminogen activator inhibitor, and antithrombin III levels in Behçet's disease. , 1995, Scandinavian journal of rheumatology.

[111]  F. Numan,et al.  Pulmonary arterial aneurysms in Behçet's syndrome: a report of 24 cases. , 1994, British journal of rheumatology.

[112]  M. Piegsa,et al.  [Retroperitoneal fibrosis]. , 1993, Deutsche medizinische Wochenschrift.

[113]  M. F. Parry,et al.  A Retrospective Analysis , 1990 .

[114]  E. Long.  Selected readings in pathology , 1961 .